This paper studies the global dynamics for discrete-time HIV infection models. The models integrate both long-lived chronically infected and short-lived infected cells. The HIV-susceptible incidence rate is taken as bilinear, saturation and general function. We discretize the continuous-time models by using nonstandard finite difference scheme. The positivity and boundedness of solutions are established. The basic reproduction number is derived. By using Lyapunov method, we prove the global stability of the models. Numerical simulations are presented to illustrate our theoretical results.
Introduction
Human immunodeficiency virus (HIV) destroys the human immune system by attacking the CD4 + T cells. Modeling within host dynamics of HIV has attracted the interest of several researchers (see, e.g., [1-3, 6-14, 19, 23, 26, 27, 32-34, 40, 41, 47] ). The basic HIV dynamics model is given by [33] :
where s, z and p are the concentrations of susceptible (uninfected) CD4 + T cells, infected cells, and free HIV particles, respectively. Parameters β, δ, andk represent the rate of birth, death, and infection of the susceptible cells, respectively. The parameters d and c are the death rate constants of the infected cells and free HIV particles, respectively. N z is the average number of HIV particles produced in the lifetime of the infected cell.
Antiretroviral drug therapies such as reverse transcriptase inhibitors (RTI) and protease inhibitors (PI) can significantly reduce the level of HIV in the blood. However, there still is a low viral load due to the presence of long-lived chronically infected cells. Callaway and Perelson [1] have proposed the following HIV dynamics model with both short-lived infected and long-lived chronically infected cells: where z and u are the concentrations of short-lived infected cells and long-lived chronically infected cells. A fraction (1 − α) and α with 0 < α < 1 are the probabilities that, upon infection, susceptible cell will become either short-lived infected or chronically infected. The parameter a is the death rate constant of the chronically infected cells. N u is the average number of HIV particles produced in the lifetime of the chronically infected cells. The chronically infected cells produce much smaller amounts of HIV than the short-lived infected cells and die at a much slower rate [1] . The RTI drug efficacy is denoted by and 0 1. Model (1.1)-(1.4) has been described by system of nonlinear ODEs, but the exact analytical solution of the model is unknown. Therefore, a discretization can be used to obtain discrete-time model which is an approximation of the exact one. Further, the use of digital computers in performing simulations necessitated the investigation of discrete-time systems. Furthermore, it is important to note that scientists often collect the data and analyze the results at discrete times. One of the very important task is to choose a discretization scheme which preserves the properties of the corresponding continuous time model. In 1994 Mickens [30] has introduced nonstandard finite difference (NSFD) scheme for solving differential equations. It has been proven that NSFD can preserve the main properties of several types of continuous time models. NSFD has been used to investigate the global stability of equilibria of the corresponding continuous time models in epidemiology [4, 5, 16, 18, 28, 39] and virology [17, 20-22, 24, 29, 35, 36, 41-46, 48] .
In this paper, our target is to study a class of discrete time HIV infection models with both short-lived infected and long-lived chronically infected cells. We study the qualitative behavior of the models with different forms of the infection rate. We investigate global stability of the equilibria of the models using Lyapunov method.
Discrete-time model
Discretizing system (1.1)-(1.4) using NSFD method as in [30] and [31] we obtain s n+1 − s n = β − δs n+1 − ks n+1 p n , (2.1)
2)
3)
where, k = (1 − )k and n ∈ N = {0, 1, 2, . . .}. We consider the initial conditions:
Preliminaries
Let us consider the region
where 
Since all parameters in (2.1)-(2.4) and the initial condition (2.5) are positive, then by induction we get s n > 0, z n > 0, u n > 0 and p n > 0 for all n ∈ N. Define a sequence M n as:
According Lemma 2.2 in [36] we obtain
By induction
Consequently, lim n→∞ sup p n N 2 . Therefore, the solution (s n , z n , u n , p n ) converges to Γ 1 as n → ∞. System (2.1)-(2.4) has two equilibria, (i) HIV-free equilibrium Q 0 (s 0 , 0, 0, 0), where s 0 = β/δ; (ii) persistent HIV equilibrium Q * (s * , z * , u * , p * ), where
Clearly, Q * exists only when R 0 > 1, where R 0 is basic reproduction number and is given by:
Global Stability
We define the function G(x) 0 as G(x) = x − ln x − 1. Hence,
Theorem 2.2. If R 0 1, then Q 0 is globally asymptotically stable.
Proof. Construct a discrete Lyapunov function L n (s n , z n , u n , p n ) as:
where η i , i = 1, 2, 3 are positive constants to be determined below. Hence, L n > 0 for all s n > 0, z n > 0, u n > 0 and p n > 0. In addition, L n = 0 if and only if s n = s 0 , z n = 0, u n = 0 and p n = 0. Computing the difference ∆L n = L n+1 − L n , as:
Using inequality (2.7), we have
From Eqs. (2.1)-(2.4), we have
Let η i , i = 1, 2, 3, be chosen such as
The solution of (2.8) is given by
The values of η i , i = 1, 2, 3, given by (2.9) will be used thought the paper. Then
Hence, for R 0 1, we have ∆L n 0 for all n 0, hence L n is a monotone decreasing sequence. we have L n 0, then there is a limit lim Proof. Define
where
Using inequality (2.7), we get
Since β = δs * + ks * p * , then
Using the conditions of Q *
we get ks
and
Thus, U n is monotone decreasing sequence. Because U n 0, there is a limit lim
Model with saturated incidence
It has been reported in [37, 38] that HIV dynamics model with saturated incidence is more accurate in case of high concentration of the HIV particles. Thus we consider the following model:
where µ is the saturation constant. Using the NSFD method we obtain
Now we study the basic and global properties of model (3.1)-(3.4).
Preliminaries
Lemma 3.1. Any solution (s n , z n , u n , p n ) of model (3.1)-(3.4) with initial conditions (2.5) is positive and ultimately bounded.
Proof. From Eqs. (3.1)-(3.4) we obtain
,
The solution of (3. (ii) persistent HIV equilibrium Q * (s * , z * , u * , p * ), where
where R 0 is given by Eq. (2.6).
Global Stability
Theorem 3.2. If R 0 1, then Q 0 is globally asymptotically stable.
where η i , i = 1, 2, 3 are given by Eq. (2.9). Hence, L n 0 for all s n > 0, z n > 0, u n > 0 and p n > 0. In addition, L n = 0 if and only if s n = s 0 , z n = 0, u n = 0 and p n = 0. Computing the difference ∆L n = L n+1 − L n as:
From Eqs. (3.1)-(3.4), we have
Hence, for R 0 1, we have ∆L n 0 for all n 0. This yields that L n is a monotone decreasing sequence. The proof can be completed similar to that of Theorem 2.2.
Theorem 3.3. If R 0 > 1, then Q * is globally asymptotically stable.
Proof. Let us consider
Clearly, U n (s n , z n , u n , p n ) > 0 for all s n , z n , u n , p n > 0 and U n (s * , z * , u * , p * ) = 0. Computing ∆U n = U n+1 − U n as:
From Eqs. (3.1)-(3.4), we have
Using the conditions of Q * β = δs * + ks * p * 1 + µp * ,
we get ks * p * 1 + µp * = η 1 dz * + η 2 au * = η 3 cp * , and
We have
Thus, U n is monotone decreasing sequence. Because U n 0, there is a limit lim 
Model with general incidence
In this section, we assume that the incidence rate is given by f(s, p), where f is a general function.
Using the NSFD method we get
Preliminaries
The function f(s, p) is assumed to satisfy the following conditions: 
When n = 0 we prove that (s 1 , z 1 , u 1 , p 1 ) exists and is positive. From Eq. (4.1) we have
Let ϕ be defined as:
From Assumption (A2), ϕ is a strictly increasing function in s 1 . Hence, there exists a unique s 1 > 0 such that ϕ(s 1 ) = 0. From Eqs. (4.5)-(4.7) we have z 1 > 0, u 1 > 0 and p 1 > 0. Therefore, by using the induction, we obtain s n > 0, z n > 0, u n > 0 and p n > 0 for all n 0. The boundedness of solutions can be shown similar to Lemma 2.1. Proof. Let Q(s, z, u, p) be any equilibrium of model (4.1)-(4.4) satisfying
αf(s, p) − au = 0, (4.10)
From Eqs. (4.8)-(4.10) we have
Substituting from Eq. (4.12) into Eq. (4.11) we get
From Assumption (A1), we have p = 0 is a solution of (4.13). Therefore, s = s 0 , z = 0 and u = 0 which leads to the HIV-free equilibrium Q 0 (s 0 , 0, 0, 0) where s 0 = β δ . If p = 0, then, from Eqs. (4.12), (4.13), we obtain
Let a function ψ 1 be defined as:
From Assumption (A1), we have ψ 1 (0) = 0, and ψ 1 (p) = −cp < 0, wherep = γβ c > 0. Moreover, It follows that, if condition (4.14) is satisfied, then there exists p * ∈ (0,p) such that ψ(p * ) = 0. Hence, we can define the basic reproduction number of system (4.1)-(4.4) as:
Moreover, let p = p * in Eq. (4.8) we get
We have ψ 2 (0) = β > 0 and ψ 2 (s 0 ) = −f(s 0 , p * ) < 0. Since f (s, p) is strictly decreasing with respect to s, then ψ 1 (s) is strictly decreasing with respect to s. Hence, there exists a unique s * ∈ (0, s 0 ) such that ψ 1 (s * ) = 0. From Eq. (4.12) and Assumption (A1) we have
This shows that if R 0 > 1, then there exists a persistent-HIV equilibrium Q * (s * , w * , u * , p * ). Proof. Define
Global stability
Hence, L n > 0 for all s n , z n , u n , p n > 0 and L n = 0 if and only if s n = s 0 , z n = 0, u n = 0 and p n = 0. Computing the difference ∆L n = L n+1 − L n as:
Using Lemma 3.1 in [22] , we get
Hence
From Eqs. (4.1)-(4.4), we have
Collecting terms of Eq (4.15) and using s 0 = β δ , we obtain
From Assumption (A4) we have
then, we get
From Assumption (A3) we have
Hence, if R 0 1, we have ∆L n 0 for all n 0. Obviously, ∆L n = 0 if and only if s n = s 0 and (R 0 − 1)p n = 0. We discuss two cases: By the aforementioned discussion, we deduce that the largest compact invariant set in {(s n , z n , u n , p n )| (∆L n ) = 0} is the just the singleton Q 0 . Therefore, Q 0 is globally asymptotically stable by the LaSalle's invariance principle [15, 25] . 
Numerical simulations
We perform our simulation by choosing Crowly Martin incidence rate
where λ > 0 and θ > 0. Therefore, system (4.1)-(4.4) becomes
For this system, the basic reproduction number is given by
We verify the assumptions (A1)-(A4) as: 
Case (I) Effect ofk of stability of equilibria:
We choose = 0.5 andk is varied as:
(i)k = 0.0001. This yields R 0 = 0.1705 < 1. Figures 1-4 show that, the concentration of susceptible cells increases and tends to the value s 0 = 1000. In addition, the concentrations of long-lived infected cells, short-lived infected cells and free HIV decrease and tend to zero for the initial values IV1-IV3. This shows that Q 0 is globally asymptotically stable and Theorem 4.3 is valid. (ii)k = 0.001. With this value we obtain R 0 = 1.7045 > 1. Figures 1-4 show that for the initial values IV1-IV3, the solutions of the system tend to the equilibrium Q * = (564.4143, 7.2953, 8.7541, 16.4141). Therefore, Q * exists and it is globally asymptotically stable. This validate the result of Theorem 4.5.
Case (II) Effect of the drug efficacy on the HIV dynamics:
For this case, we take IV2 and choose the valuek = 0.001 and is varied. Figures 5-8 and Table 1 show the effect of drug efficacy on the stability of the system. We observe that, as is increased, the infection rate is decreased, then, the concentration of the susceptible cells are increased, while the concentrations of the long-lived infected cells, short-lived infected cells and free HIV particles are decreased. In addition 
